Intelligent Molecular Therapeutics (IMT) is the process of developing intelligent molecules in order to solve health problems biologically -- not chemically. IMT harnesses the therapeutic capabilities of specific molecules, enabling us to acutely evaluate the state of a cell in order to determine the level of action required based on a set of triggers. Only if those triggers are found will the technology deliver the therapeutic solution.
Biiosmart is a pioneer in the creation of intelligent molecular therapeutics. We specialize in the reluctant pursuit of exploring molecular curiosity.
We explore our platform technology from within to identify various areas of application. Our people constantly screen the interaction between the developed molecules and their target subject until a promising candidate is discovered.
Each candidate is refined comprehensively through stability, safety, efficacy, and biocompatibility testing before being approved for human trials. Once the point of intelligence has been confirmed, production testing can be formulated for clinical use.
A clinical trial is conducted with human volunteers who test the intelligence of the candidate, whether prevention or treatment. Our partners in research are fundamental in the advancement of innovative therapies.
When a candidate has completed successful clinical trials, it is then submitted for review by local regulatory agencies. Ongoing investigation is continued to review findings and explore new developments.
Infectious Disease
Respiratory
Sexually Transmitted
Infections
Wound care
Dermatology
Gastroenterology
Infections